Patient Rights Regarding Restraint and Seclusion in Care Settings

Federal regulations and accreditation standards govern when and how healthcare facilities may use restraint or seclusion — physical and environmental restrictions that limit a patient's freedom of movement or ability to interact with the environment. These protections apply in hospitals, psychiatric units, residential treatment facilities, and certain outpatient behavioral health settings across the United States. Understanding these rights is foundational to patient rights during hospitalization and intersects directly with mental health patient rights in institutional settings. The regulatory framework reflects decades of documented harm resulting from improper use of these interventions.

Definition and scope

Restraint and seclusion are defined and regulated under two primary federal frameworks: the Centers for Medicare and Medicaid Services (CMS) Conditions of Participation (CoP) at 42 CFR Part 482, Subpart E, and the Joint Commission's accreditation standards for hospitals and behavioral health organizations.

Restraint is defined by CMS as any manual method, physical or mechanical device, material, or equipment that immobilizes or reduces the ability of a patient to move arms, legs, body, or head freely. This includes chemical restraint — the use of a drug administered as a restriction of freedom of movement rather than as a standard treatment for a medical or psychiatric condition.

Seclusion is the involuntary confinement of a patient alone in a room or area from which the patient is physically prevented from leaving.

CMS distinguishes between two categories of restraint use:

Medical/surgical restraint — used when a patient's physical safety would be at immediate risk without the intervention (e.g., preventing a patient from removing a life-sustaining device).
Behavioral health restraint or seclusion — used when a patient's behavior presents an imminent danger to self or others, and no less-restrictive intervention has been effective.

These categories carry different procedural requirements, monitoring intervals, and physician involvement timelines. The scope of federal protections applies to all Medicare- and Medicaid-participating facilities, which encompasses the vast majority of licensed hospitals and certified psychiatric residential treatment facilities (PRTFs) in the United States.

How it works

Federal regulations establish a structured framework of procedural requirements designed to limit the use of restraint and seclusion to genuine emergencies of last resort. The CMS CoP at 42 CFR §482.13(e)–(f) outlines the following sequence:

Least-restrictive alternative required — Staff must first attempt and document the failure of less-restrictive interventions before applying restraint or seclusion.
Physician or licensed independent practitioner (LIP) order — Restraint or seclusion must be ordered by a LIP responsible for the patient's care. In behavioral emergencies, a trained registered nurse may initiate the intervention but a LIP must be contacted immediately and must provide an order within 1 hour.
Time-limited orders — Behavioral restraint and seclusion orders are time-limited: 4 hours for adults (18 and older), 2 hours for children ages 9–17, and 1 hour for children under 9, per 42 CFR §482.13(e)(8).
In-person evaluation — A physician or LIP must conduct an in-person evaluation of the patient within 1 hour of the initiation of behavioral restraint or seclusion.
Continuous monitoring — Patients in behavioral restraint or seclusion must be continuously monitored by trained staff, face-to-face. Medical/surgical restraint requires monitoring at minimum every 2 hours.
Reassessment and release — The patient must be released from restraint or seclusion at the earliest possible moment. Restraint or seclusion must be discontinued as soon as the patient no longer meets the criteria for its use.
Death and serious injury reporting — Deaths that occur while a patient is in restraint or seclusion, or within 24 hours of removal, must be reported to CMS. Deaths in a PRTF must also be reported to the Secretary of Health and Human Services (42 CFR §483.358).

Patient rights under this framework include the right to be free from restraint or seclusion imposed as a means of coercion, discipline, convenience, or retaliation — a prohibition stated explicitly in CMS regulations.

Common scenarios

Restraint and seclusion rights apply across a range of clinical contexts. Three primary scenarios define the operational boundaries:

Acute inpatient psychiatric settings represent the most frequent site of behavioral restraint and seclusion use. Patients admitted voluntarily or involuntarily to a psychiatric unit retain the same federal rights under CMS CoP. Facilities accredited by The Joint Commission must additionally comply with Joint Commission Standard PC.03.05.01, which requires debriefing with the patient following each restraint or seclusion episode and prohibits prone restraint in most circumstances.

General medical and surgical hospitals use medical/surgical restraint most often in intensive care settings — for example, to prevent a sedated patient from removing an endotracheal tube. In this context, the restraint order must be renewed every 24 hours rather than the shorter intervals required for behavioral use.

Residential treatment facilities for children and adolescents are subject to additional federal rules. Psychiatric residential treatment facilities receiving Medicaid funding must meet requirements at 42 CFR Part 483, Subpart G, which imposes stricter monitoring and independent review requirements than those applied to adult settings.

Detailed protections for younger patients in institutional settings are addressed on the pediatric patient rights page.

Decision boundaries

Regulatory bright lines govern when restraint and seclusion are categorically prohibited or restricted:

Restraint as punishment is prohibited — CMS regulations state that restraint may not be used as a means of punishment, regardless of patient behavior.
Prone restraint restrictions — The Joint Commission prohibits the use of prone restraint (face-down) that compromises the patient's airway or breathing. Multiple state regulatory bodies have enacted similar or stricter rules following documented deaths from positional asphyxia.
Seclusion is not permitted in medical/surgical settings — Seclusion under the CMS definition applies exclusively in behavioral health contexts. Confining a medical patient alone in a room in a manner intended to restrict their movement without clinical justification raises both regulatory and civil rights concerns under anti-discrimination rights in healthcare.
Chemical restraint is a distinct category — Administering medication for the purpose of restricting movement rather than as standard treatment constitutes chemical restraint and is subject to the same procedural requirements as physical restraint under CMS rules.
Voluntary vs. involuntary admission does not eliminate rights — Voluntary psychiatric patients retain all CMS-defined rights regarding restraint and seclusion. Voluntary admission status does not authorize a facility to apply greater physical control.

The question of right to refuse treatment intersects directly with restraint decisions when a patient objects to a proposed intervention. CMS regulations require that the patient's right to refuse must be weighed against documented imminent safety risk — refusal alone does not authorize restraint.

Patients and families seeking to understand the full scope of protections in institutional settings can consult the patient safety rights reference, as well as filing a patient grievance for procedural guidance when violations are alleged.

References

Explore This Site

Regulations & Safety Regulatory References Tools & Calculators Bmi Health Metrics Calculator